PMID: 3757477Sep 1, 1986Paper

In vitro activities of 17 antimicrobial agents against the formate/fumarate-requiring, anaerobic gram-negative bacilli

Diagnostic Microbiology and Infectious Disease
C C JohnsonSydney M Finegold

Abstract

The in vitro activities of 17 antimicrobial agents were evaluated against 46 clinical isolates of formate/fumarate-requiring anaerobic gram-negative bacilli. Strains of Bacteroides ureolyticus (23) were almost uniformly susceptible to the tested antimicrobials, whereas strains of Bacteroides gracilis (18) showed some striking resistance with penicillin active against only 67%, the cephalosporins active against 67%-89%, and clindamycin active against 67%. Although few strains of Wolinella species/C. concisus (5) were available for testing, these isolates tended to be more resistant than B. ureolyticus but less resistant than B. gracilis.

References

Mar 1, 1984·Reviews of Infectious Diseases·J E Rosenblatt

❮ Previous
Next ❯

Citations

Mar 27, 2003·International Endodontic Journal·J F Siqueira, I N Rôças
Aug 9, 2018·Frontiers in Cellular and Infection Microbiology·Fang LiuLi Zhang
Aug 1, 1990·Journal of Clinical Microbiology·K LeeS M Finegold
Oct 1, 1991·Clinical Microbiology Reviews·H M Wexler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.